Athos Capital’s AEON Biopharma Inc AEON.WS Stock Holding History

Athos Capital’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-25,417	Closed	-$295K	–	51
2024 Q1	$295K	Hold	25,417	–	–	0.32%	29
2023 Q4	$179K	Hold	25,417	–	–	0.2%	31
2023 Q3	$143K	Buy	+25,417	New	+$3.6K	0.07%	49
2023 Q2	–	Sell	-29,768	Closed	-$302K	–	77
2023 Q1	$302K	Hold	29,768	–	–	0.21%	67
2022 Q4	$299K	Hold	29,768	–	–	0.17%	87
2022 Q3	$293K	Hold	29,768	–	–	0.12%	110
2022 Q2	$292K	Hold	29,768	–	–	0.11%	122
2022 Q1	$291K	Hold	29,768	–	–	0.1%	112
2021 Q4	$289K	Hold	29,768	–	–	0.09%	115
2021 Q3	$290K	Hold	29,768	–	–	0.07%	132
2021 Q2	$287K	Buy	+29,768	New	+$22.6K	0.06%	150

Athos Capital's AEON.WS Position: Q2 2024 in Review

Athos Capital sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 25,417 shares — an estimated $295K sold.

Athos Capital first reported a position in AEON.WS in Q2 2021 and held it in 11 quarters. The position peaked at $302K in Q1 2023. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Athos Capital reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Athos Capital sold 25,417 AEON Biopharma Inc shares in Q2 2024, an estimated $295K.
Athos Capital first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 11 quarters.
Athos Capital's AEON Biopharma Inc position peaked at $302K in Q1 2023.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Athos Capital's 13F filing for Q2 2024, filed 14 Aug 2024.